Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection

Patients with inflammatory bowel disease (IBD) are at risk of developing haemophagocytic lymphohistiocytosis (HLH) because of chronic systemic inflammation as well as exposure to immunosuppressive medications. The two main causes of HLH in IBD patients are infection with cytomegalovirus and Epstein-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Xia, Xuefeng, Zhang, Jing, Song, Zhiqiang, Zhou, Liya, Zhang, Yaopeng, Huang, Yonghui, Shi, Yanyan, Quigley, Eamonn M.M., Ding, Shigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631275/
https://www.ncbi.nlm.nih.gov/pubmed/26557937
http://dx.doi.org/10.5114/pg.2015.48995
_version_ 1782398833535221760
author Li, Yuan
Xia, Xuefeng
Zhang, Jing
Song, Zhiqiang
Zhou, Liya
Zhang, Yaopeng
Huang, Yonghui
Shi, Yanyan
Quigley, Eamonn M.M.
Ding, Shigang
author_facet Li, Yuan
Xia, Xuefeng
Zhang, Jing
Song, Zhiqiang
Zhou, Liya
Zhang, Yaopeng
Huang, Yonghui
Shi, Yanyan
Quigley, Eamonn M.M.
Ding, Shigang
author_sort Li, Yuan
collection PubMed
description Patients with inflammatory bowel disease (IBD) are at risk of developing haemophagocytic lymphohistiocytosis (HLH) because of chronic systemic inflammation as well as exposure to immunosuppressive medications. The two main causes of HLH in IBD patients are infection with cytomegalovirus and Epstein-Barr virus. Patients with Crohn's disease are more susceptible to HLH than those with ulcerative colitis. The majority of cases are seen in people receiving an immunosuppressive regimen that included thiopurines.
format Online
Article
Text
id pubmed-4631275
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-46312752015-11-10 Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection Li, Yuan Xia, Xuefeng Zhang, Jing Song, Zhiqiang Zhou, Liya Zhang, Yaopeng Huang, Yonghui Shi, Yanyan Quigley, Eamonn M.M. Ding, Shigang Prz Gastroenterol Review Paper Patients with inflammatory bowel disease (IBD) are at risk of developing haemophagocytic lymphohistiocytosis (HLH) because of chronic systemic inflammation as well as exposure to immunosuppressive medications. The two main causes of HLH in IBD patients are infection with cytomegalovirus and Epstein-Barr virus. Patients with Crohn's disease are more susceptible to HLH than those with ulcerative colitis. The majority of cases are seen in people receiving an immunosuppressive regimen that included thiopurines. Termedia Publishing House 2015-10-02 2015 /pmc/articles/PMC4631275/ /pubmed/26557937 http://dx.doi.org/10.5114/pg.2015.48995 Text en Copyright © 2015 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Paper
Li, Yuan
Xia, Xuefeng
Zhang, Jing
Song, Zhiqiang
Zhou, Liya
Zhang, Yaopeng
Huang, Yonghui
Shi, Yanyan
Quigley, Eamonn M.M.
Ding, Shigang
Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection
title Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection
title_full Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection
title_fullStr Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection
title_full_unstemmed Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection
title_short Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection
title_sort haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631275/
https://www.ncbi.nlm.nih.gov/pubmed/26557937
http://dx.doi.org/10.5114/pg.2015.48995
work_keys_str_mv AT liyuan haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT xiaxuefeng haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT zhangjing haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT songzhiqiang haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT zhouliya haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT zhangyaopeng haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT huangyonghui haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT shiyanyan haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT quigleyeamonnmm haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection
AT dingshigang haemophagocyticlymphohistiocytosisininflammatoryboweldiseasewithvirusinfection

Ejemplares similares